InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Discover the detailed record of transactions filed by Sandercock Brett, Chief Financial Officer. Director active across 1 companies, notably RESMED INC. Cumulatively, 27 disclosures have been recorded. Total volume traded: €3.9m. The latest transaction was disclosed on 11 April 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations27 total
€132,7452,500 shares@ €53.09820.0004% mcap0.9% of flow
ResMed Common Stock
SEC:0001127602-22-011914:0·
€130,3982,500 shares@ €52.1590.0003% mcap0.9% of flow
ResMed Common Stock
SEC:0001127602-22-009063:0·
€126,4282,500 shares@ €50.57120.0003% mcap0.8% of flow
ResMed Common Stock
SEC:0001127602-22-004725:0·
€127,1802,500 shares@ €50.87210.0003% mcap1.7% of flow
ResMed Common Stock
SEC:0001127602-22-001337·
€127,1802,500 shares@ €50.87210.0003% mcap0.8% of flow
ResMed Common Stock
SEC:0001127602-22-001337:0·
€127,8632,500 shares@ €51.14530.0003% mcap1.7% of flow
ResMed Common Stock
SEC:0001127602-21-030901·
€127,8632,500 shares@ €51.14530.0003% mcap0.8% of flow
ResMed Common Stock
SEC:0001127602-21-030901:0·
€5m20,360 shares@ €224.17670.012% mcap61.6% of flow
ResMed Common Stock
SEC:0001127602-21-029582·
€5m20,360 shares@ €224.17670.012% mcap30.0% of flow
ResMed Common Stock
SEC:0001127602-21-029582:0·
€124,5312,500 shares@ €49.81220.0003% mcap1.7% of flow
ResMed Common Stock
SEC:0001127602-21-028929·
€124,5312,500 shares@ €49.81220.0003% mcap0.8% of flow
ResMed Common Stock
SEC:0001127602-21-028929:0·
€124,9812,500 shares@ €49.99240.0003% mcap1.7% of flow
ResMed Common Stock
SEC:0001127602-21-026987·
€124,9812,500 shares@ €49.99240.0003% mcap0.8% of flow
ResMed Common Stock
SEC:0001127602-21-026987:0·
€122,1052,500 shares@ €48.84190.0003% mcap1.6% of flow
ResMed Common Stock
SEC:0001127602-21-025210·
€122,1052,500 shares@ €48.84190.0003% mcap0.8% of flow
ResMed Common Stock
SEC:0001127602-21-025210:0·
€256,8795,193 shares@ €49.46650.0007% mcap3.5% of flow
ResMed Common Stock
SEC:0001127602-21-024177·
€256,8795,193 shares@ €49.46650.0007% mcap1.7% of flow
ResMed Common Stock
SEC:0001127602-21-024177:0·
04,784 shares0
ResMed Common Stock
SEC:0001127602-21-024094·
04,784 shares0
ResMed Common Stock
SEC:0001127602-21-024094:0·
€592,9422,500 shares@ €237.17660.0016% mcap8.0% of flow
ResMed Common Stock
SEC:0001127602-21-023535·
€592,9422,500 shares@ €237.17660.0016% mcap3.9% of flow
ResMed Common Stock
SEC:0001127602-21-023535:0·
€523,5052,500 shares@ €209.40210.0014% mcap7.1% of flow
ResMed Common Stock
SEC:0001127602-21-021895·
€523,5052,500 shares@ €209.40210.0014% mcap3.4% of flow
ResMed Common Stock
SEC:0001127602-21-021895:0·
€437,1312,500 shares@ €174.85230.0012% mcap5.9% of flow
ResMed Common Stock
SEC:0001127602-21-019756·
€437,1312,500 shares@ €174.85230.0012% mcap2.9% of flow
ResMed Common Stock
SEC:0001127602-21-019756:0·
25 of 27 declarations
About Sandercock Brett
Brett Sandercock is an executive at RESMED INC.
